COMMUNIQUÉS West-GlobeNewswire

Virbac : Déclaration d'actions et de droits de vote au 31 Octobre 2017

02/11/2017 - 16:14

DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]

Virbac : Declaration of the number of shares and voting rights as of October 2017, 31.

02/11/2017 - 16:14

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]

LIDDS: New website and change of web address

02/11/2017 - 16:13

LIDDS has today launched a newly designed website that will better reflect the ongoing company activities and the NanoZolid ® project development pipeline. At the same time the web address is changed to www.liddspharma. [...]

Sanofi and Alnylam present positive complete results from APOLLO Phase 3 study of investigational patisiran in hereditary ATTR (hATTR) amyloidosis patients with polyneuropathy

02/11/2017 - 15:45

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Alnylam present positive complete results from APOLLO Phase 3 study of investigational patisiran in hereditary ATTR (hATTR) amyloidosis patients with [...]

Sanofi et Alnylam présentent les résultats positifs complets de l'étude de phase 3 APOLLO consacrée à l'agent expérimental patisiran dans le traitement de l'amylose héréditaire à transthyrétine ave...

02/11/2017 - 15:45

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Sanofi et Alnylam présentent les résultats positifs complets de l'étude de phase 3 APOLLO consacrée à l'agent expérimental patisiran dans le traitement [...]

Solon Eiendom ASA : Invitation to presentation of third quarter 2017 results

02/11/2017 - 15:15

Oslo, 02 November 2017 - Solon Eiendom ASA will publish its third quarter 2017 results on Thursday 09 November at 06.30 am CET. The quarterly report and the presentation will be available on the company's web site, www. [...]

Solon Eiendom ASA : Invitasjon til presentasjon av 3.kvartal 2017

02/11/2017 - 15:15

Oslo, 02 November 2017 - Solon Eiendom ASA publiserer resultatet for 3.kvartal 2017 torsdag 09. november kl 06.30. Kvartalsrapporten og markedspresentasjon vil bli gjort tilgjengelig på selskapets hjemmeside, www. [...]

Medtronic Evolut(TM) PRO TAVR System with Advanced Sealing Maintains Excellent Outcomes Over Time

02/11/2017 - 15:00

Evolut PRO Valve Well-Positioned for Future with New Study Unveiled to Investigate Expanded Patient Population DUBLIN and DENVER - November 2, 2017 - Medtronic plc (NYSE:MDT) today presented new data at the [...]

Vistin Pharma ASA : Minutes from Extraordinary General Meeting

02/11/2017 - 13:45

Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the extraordinary general meeting held on 2 November 2017. All matters were resolved as proposed in the call for the extraordinary general meeting. [...]

Genedrive PLC: Update on Distribution arrangements for India / SAARC

02/11/2017 - 13:00

2 November 2017 genedrive plc ("genedrive" or the "Company") Update on Distribution arrangements for India / SAARC [1] genedrive plc (LSE:GDR), the molecular diagnostics company, today provides an update on its [...]

NuCana plc to Present at the Jefferies 2017 London Healthcare Conference

02/11/2017 - 13:00

EDINBURGH, United Kingdom, Nov. 02, 2017 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying its [...]

AC Immune SA to Receive Milestone Payment for Anti-Tau Antibody Moving into Phase 2 Trial for Alzheimer's Disease

02/11/2017 - 11:22

AC Immune to receive third milestone payment of CHF 14 million under collaboration agreement with Genentech Phase 2 to evaluate effects of anti-Tau antibody in people with prodromal-to-mild Alzheimer's disease Phase 1 [...]

Affimed to Present at the 26th Annual Credit Suisse Healthcare Conference

02/11/2017 - 10:58

Heidelberg, Germany, November 2, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi [...]

Navamedic ASA: Invitation to presentation of third quarter results 2017

02/11/2017 - 10:20

Navamedic ASA invites you to a presentation of the third quarter 2017 figures. The presentation takes place at Hotel Continental, Stortingsgaten 24/26, 0117 Oslo, Friday 10 November. The presentation will start at 08.00 [...]

Navamedic ASA: Invitation to presentation of third quarter results 2017

02/11/2017 - 09:48

Navamedic ASA invites you to follow an online presentation of the third quarter 2017 figures. The presentation will be webcasted at www.navamedic.com - investor relations - presentations - webcast on Friday 10.11 2017 [...]

Photocure ASA:U.S. CMS improves reimbursement for Blue Light Cystoscopy with Cysview®

02/11/2017 - 08:07

Oslo, Norway, November 2,2017: Photocure ASA (OSE: PHO), announced today that the United States Centers for Medicare & Medicaid Services (CMS) has issued a Final Rule stating that it will reimburse hospital [...]

Notice to Attend the Extraordinary General Meeting of Immunicum

02/11/2017 - 07:40

Press Release 2 November 2017 Notice to Attend the Extraordinary General Meeting of Immunicum The shareholders of Immunicum AB (publ) (the "Company"), reg. no 556629-1786, are hereby invited to an Extraordinary General [...]

Zealand reports royalty revenue for the third quarter of 2017

02/11/2017 - 07:39

Company announcement - No. 49/2017 Zealand reports royalty revenue for the third quarter of 2017 Zealand reports royalty revenue of DKK 10.3 million/USD 1.6 million for Q3 2017 The revenue is based on total net sales of [...]

Galapagos moving forward in CF programs at NACFC 2017

02/11/2017 - 07:30

Ten posters and four oral presentations reflect progress toward triple combination therapy Mechelen, Belgium; 2 November 2017; 7.30 CET - At the North American Cystic Fibrosis Conference (NACFC) 2017, Galapagos NV ( [...]